Apr 12, 2019 EASL 2019 Pharmacokinetics Safety and Tolerability of Seladelpar in Subjects with Hepatic Impairment
Apr 12, 2019 Comparison of Seladelpar and Combinations with Liraglutide or Selonsertib for Improvement of Fibrosis and NASH in a Diet-Induced and Biopsy-Confirmed Mouse Model of NASH
Apr 12, 2019 Treatment of Patients with Primary Biliary Cholangitis with Seladelpar for 52 Weeks Improves Predicted Transplant-free Survival
Apr 12, 2019 Seladelpar for the Treatment of Primary Biliary Cholangitis: Experience with 25 Cirrhotic Patients
Jan 21, 2019 Efficacy of Seladelpar for Amelioration of Fibrosis and NASH in a Diet-Induced and Biopsy- Confirmed Mouse Model: Comparison to Liraglutide, Selonsertib and Obeticholic Acid
Jan 15, 2019 Combination Therapy of Seladelpar and Liraglutide Attenuates Obesity, Hepatic Steatosis and Fibrosis in a Diet Mouse Model of NASH
Nov 13, 2018 Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, Randomized, Dose-Ranging Phase 2 Study
Nov 12, 2018 Efficacy and Safety of Seladelpar in Primary Biliary Cholangitis 52-Week Analysis of a Dose-Ranging Phase 2 Study
Nov 10, 2018 Seladelpar Improves Hepatic Steatohepatitis and Fibrosisin a Diet-Induced and Biopsy-Confirmed Mouse Model of NASH